MarketPeel
Insider Trading Intelligence
JC

Jason V. Coloma

MAZE
CHIEF EXECUTIVE OFFICER · MAZE THERAPEUTICS, INC. · CIK 0001676170
FILING MIX · LIFETIME19%/81%
BUYS
3
SELLS
13
TOTAL VALUE
$2.83M
COMPANIES
1
ACTIVE SINCE
Sep 2025
HOLDINGS NOW
23,337
AVG SELL PX
$27.35
TRADE KIND
SHOWING 16 / 16
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Jason V. Coloma. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
MAZE · 23,337 shares · as of Jul 1, 2026
095,268190,537285,805381,0732026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2025
2025
2026
2026
2026
FLOW · 3 buys / 13 sellsCOVERAGE · 5 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
MAZE
MAZE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,593$29.98$77.7K23,337Jul 1, 2026Jul 2, 2026View →
MAZE
MAZE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,597$30.44$48.6K287,171Jul 1, 2026Jul 2, 2026View →
MAZE
MAZE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
30,311$29.95$907.9K288,768Jul 1, 2026Jul 2, 2026View →
MAZE
MAZE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
23,865$26.05$621.7K319,079Jun 23, 2026Jun 24, 2026View →
MAZE
MAZE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,953$26.00$50.8K342,944Jun 22, 2026Jun 24, 2026View →
MAZE
MAZE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,040$26.00$53.0K25,930Jun 22, 2026Jun 24, 2026View →
MAZE
MAZE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
6,090$26.20$159.5K344,897Jun 1, 2026Jun 3, 2026View →
MAZE
MAZE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
553$26.24$14.5K27,970Jun 1, 2026Jun 3, 2026View →
MAZE
MAZE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
25,582$26.02$665.5K350,987May 26, 2026May 27, 2026View →
MAZE
MAZE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
4,504$26.00$117.1K376,569May 22, 2026May 27, 2026View →
MAZE
MAZE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,478$26.00$64.4K28,523May 22, 2026May 27, 2026View →
MAZE
MAZE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
116$26.00$3.0K31,001May 15, 2026May 18, 2026View →
MAZE
MAZE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,822$26.00$47.4K381,073May 15, 2026May 18, 2026View →
MAZE
MAZE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
150,000150,000Mar 2, 2026Mar 3, 2026View →
MAZE
MAZE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
75,00075,000Mar 2, 2026Mar 3, 2026View →
MAZE
MAZE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
100,000100,000Sep 22, 2025Sep 24, 2025View →
Other insiders · MAZE
Loading peer insiders…
About this filer
CIK 0001676170
ROLE
Chief Executive Officer
PRIMARY
MAZE
COMPANIES
1
ACTIVE SINCE
Sep 2025
MARKETPEEL · /INSIDER/0001676170DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback